Hematology Analyzers Market Size

  • Report ID: 3295
  • Published Date: Nov 05, 2025
  • Report Format: PDF, PPT

Hematology Analyzers Market Outlook:

Hematology Analyzers Market was valued at USD 8 billion in 2025 and is forecasted to reach a valuation of USD 16.1 billion by the end of 2036, rising at a CAGR of 7.2% during the forecast period, i.e., 2026-2036. In 2026, the industry size of the hematology analyzers is estimated at USD 8.6 billion.

The rapid increase in the prevalence of hematological and chronic disorders is influencing the continuous expansion of the global hematology analyzers market. As estimated by the Leukemia & Lymphoma Society, 187,740 people were diagnosed with such as leukemia, myeloma, and lymphoma in 2024 in the U.S. Among the estimated 2,001,140 new cases of cancer within the country, 9.4% were of leukemia, myeloma, and lymphoma. As disclosed by the American Society of Hematology in May 2025, patients with different hematological disorders are treated by hematologists across all continents. The conditions of hematology practices and access to proper research and development ecosystems vary from region to region. In November 2023, the same reporting authority also predicted that the number of detected hematological malignancies is estimated to increase to around 4,634,937 by 2030 globally. Proper treatment of hematological diseases requires continuous monitoring, driving the demand for advanced and automated analyzers.

Relevant technological advancements are also fueling the hematology analyzers market growth. Modern hematology analyzers are enabled with a range of sophisticated detection methods, AI, automation, and software, shifting the process of blood cell analysis from the use of traditional laboratory equipment to a more appropriate and efficient diagnostic tool.  A vast pool of companies is contributing to increasing the market accessibility to advanced hematology analyzers. For instance, in July 2023, Sysmex Corporation launched the XR-Series of hematology analyzers. The new product line was built upon XN-Series technology and its predecessor, and delivers improved throughput to fulfill the laboratory needs.


Hematology Analyzers Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of the hematology analyzers market in the was over USD 8 billion.

The market size for the hematology analyzers is projected to reach USD 16.1 billion by the end of 2036, expanding at a CAGR of 7.2% during the forecast period, i.e., between 2026-2036.

The major players in the market are Abbott Laboratories, Sysmex Corporation, Beckman Coulter, Siemens Healthineers, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Bio-Rad Laboratories.

The complete blood count (CBC) segment is anticipated to garner the largest market share by 2036 and display lucrative growth opportunities during 2026-2036.

The North America market is projected to hold the largest market share of by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos